Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (71-80 of 451) with videos related to

Pageof 46
Sort By:
Frontiers in Microbiology|May 3, 2021
Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive BacteriaLewisOscar Felix, Eleftherios Mylonakis, Beth Burgwyn Fuchs
Thyroid : Official Journal of the American Thyroid Association|August 24, 2002
Human immunodeficiency virus infection and the thyroidPolyxeni Koutkia, Eleftherios Mylonakis, Robert M Levin
Haematologica|May 21, 2009
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenancePanayiotis D Ziakas, Petros Karsaliakos, Eleftherios Mylonakis
Expert Opinion on Pharmacotherapy|March 20, 2012
Update on the epidemiology and management of cryptococcal meningitisAthanasios Desalermos, Themistoklis K Kourkoumpetis, Eleftherios Mylonakis
Methods in Molecular Biology (Clifton, N.J.)|March 26, 2014
Nonmammalian model systems to investigate fungal biofilmsMarios Arvanitis, Beth Burgwyn Fuchs, Eleftherios Mylonakis
Critical Care Medicine|October 23, 2013
The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studiesPanayiotis D Ziakas, Theodora Anagnostou, Eleftherios Mylonakis
FEMS Yeast Research|May 16, 2006
The pursuit of cryptococcal pathogenesis: heterologous hosts and the study of cryptococcal host-pathogen interactionsRoanna London, Benjamin Samuel Orozco, Eleftherios Mylonakis
Virulence|January 5, 2012
Virulence: The first two yearsEva M Riedmann, Sara Sharpe, Eleftherios Mylonakis
Current Opinion in Pharmacology|September 3, 2013
C. elegans for anti-infective discoveryMarios Arvanitis, Justin Glavis-Bloom, Eleftherios Mylonakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverageElias K Spanakis, George Aperis, Eleftherios Mylonakis
Pageof 46

Showing results (71-80 of 451) with videos related to

Sort By:
Pageof 46
Frontiers in Microbiology|May 3, 2021
Thioredoxin Reductase Is a Valid Target for Antimicrobial Therapeutic Development Against Gram-Positive BacteriaLewisOscar Felix, Eleftherios Mylonakis, Beth Burgwyn Fuchs
Thyroid : Official Journal of the American Thyroid Association|August 24, 2002
Human immunodeficiency virus infection and the thyroidPolyxeni Koutkia, Eleftherios Mylonakis, Robert M Levin
Haematologica|May 21, 2009
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenancePanayiotis D Ziakas, Petros Karsaliakos, Eleftherios Mylonakis
Expert Opinion on Pharmacotherapy|March 20, 2012
Update on the epidemiology and management of cryptococcal meningitisAthanasios Desalermos, Themistoklis K Kourkoumpetis, Eleftherios Mylonakis
Methods in Molecular Biology (Clifton, N.J.)|March 26, 2014
Nonmammalian model systems to investigate fungal biofilmsMarios Arvanitis, Beth Burgwyn Fuchs, Eleftherios Mylonakis
Critical Care Medicine|October 23, 2013
The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU Setting: a meta-analysis of published studiesPanayiotis D Ziakas, Theodora Anagnostou, Eleftherios Mylonakis
FEMS Yeast Research|May 16, 2006
The pursuit of cryptococcal pathogenesis: heterologous hosts and the study of cryptococcal host-pathogen interactionsRoanna London, Benjamin Samuel Orozco, Eleftherios Mylonakis
Virulence|January 5, 2012
Virulence: The first two yearsEva M Riedmann, Sara Sharpe, Eleftherios Mylonakis
Current Opinion in Pharmacology|September 3, 2013
C. elegans for anti-infective discoveryMarios Arvanitis, Justin Glavis-Bloom, Eleftherios Mylonakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverageElias K Spanakis, George Aperis, Eleftherios Mylonakis
Pageof 46